Search
Filter by content type
Filter by content year
Filter by category
BioNTech and DualityBio Receive FDA Fast Track Designation for Next-Generation Antibody-Drug Conjugate Candidate BNT325/DB-1305
January 31, 2024 - … pharmaceutical collaborators, including Duality Biologics, Fosun Pharma, Genentech, a member of the Roche Group, … pharmaceutical collaborators, including Duality Biologics, Fosun Pharma, Genentech, a member of the Roche Group, … pharmaceutical collaborators, including Duality Biologics, Fosun Pharma, Genentech, a member of the Roche Group, …
BioNTech und DualityBio erhalten Fast-Track-Status der FDA für innovativen Antikörper-Wirkstoff-Konjugat-Kandidat BNT325/DB-1305
January 31, 2024 - … aus der pharmazeutischen Industrie, darunter DualityBio, Fosun Pharma, Genentech (ein Unternehmen der Roche Gruppe), … aus der pharmazeutischen Industrie, darunter DualityBio, Fosun Pharma, Genentech (ein Unternehmen der Roche Gruppe), … aus der pharmazeutischen Industrie, darunter DualityBio, Fosun Pharma, Genentech (ein Unternehmen der Roche Gruppe), …